Introduction
Breast cancer remains the most common malignancy in women, and despite the efforts that have been expended on its early detection, half a million people died from this disease in 2012. 1 Early breast cancer is now considered potentially curable and tamoxifen administration is the standard endocrine therapy of hormone receptor positive breast cancer. This is not the case for metastatic breast cancers, which are heterogeneous, often resistant to apoptosis and consequently difficult to cure. Thus, the search for new drugs with mechanisms of action different from those already in use is urgently needed. Some of us introduced some time ago the ferrocenyl analogues of OH-tamoxifen (OH-Tam [2] , Chart 1), an active metabolite of tamoxifen. 2, 3 Not only did these compounds have an antioestrogenic effect on hormone-dependent breast cancer cells, but they also displayed high cytotoxicity on the triple negative breast cell line MDA-MB-231 (IC 50 = 0.5 µM for Fc-OH-Tam) 3 as well as on a panel of cells resistant to apoptosis (glioma and melanoma). 4, 5 Chart 1 Formulae of the compounds under study.
In addition, Fc-OH-Tam significantly inhibited in vivo growth of MDA-MB-231 xenografted tumours in mice when formulated in lipid nanocapsules (LNCs). 4 Regarding the mechanism of action of this complex, we found that Fc-OH-Tam induced strong senescence in MDA-MB-231 and low apoptosis. 6 These remarkable properties have been linked to the presence of the [Fc-ene-phenol] motif that is selectively activated in cancer cells, therefore revealing their redox environment. 7 As such, Fc-OH-Tam acts as a prodrug whose cytotoxicity is associated with its oxidation to a highly electrophilic quinone methide. 7 More recently we found that the quinone methide of Fc-OH-Tam was able to strongly inhibit the enzyme thioredoxin reductase (TrxR) in vitro. 8 TrxR belongs to the thioredoxin system, which, together with the glutathione system, is responsible for thiol redox homeostasis. It is present as cytosolic (TrxR1) and mitochondrial (TrxR2) isoforms, displaying a selenocysteine residue at its C-terminal active site, which acts as a major target of electrophiles as well as many metal complexes. [9] [10] [11] [12] TrxR is often overexpressed in cancer cells and its inhibition may lead to cell apoptosis. 13, 14 Fc-OH-Tam inhibits TrxR in Jurkat cells, indicating that its conversion to quinone methide occurs in cellulo via endogenous oxidizing systems. Recent studies on the tamoxifen-like complex of osmium (Oc-OH-Tam, Chart 1) showed that in vitro inhibition of TrxR only occurred after its enzymatic oxidation by the HRP/H 2 O 2 mixture. Although less cytotoxic than Fc-OH-Tam on the MDA-MB-231 cell line (IC 50 = 2.7 µM), 15 Oc-OH-Tam proved to be an effective inhibitor of TrxR in Jurkat cells, inducing mitochondrial dysfunction and cell death. 16 To gain better insight into the mechanism of action of tamoxifen-like metallocifens (TLMs) and to evaluate the role played by the metallocenic unit we report here the comparison of some biological effects of TLMs of iron, ruthenium and osmium with those of their organic tamoxifen analogues (Chart 1). Experiments included in vitro studies on purified cytosolic and mitochondrial isoforms of TrxR (TrxR1 and TrxR2) followed by studies on mitochondrial functionality in Jurkat cells. In particular, the redox state of mitochondrial Trx, ROS level and mitochondrial membrane potential (MMP) were measured. In addition, the intracellular distribution of metals was determined using ICP-OES measurements.
Overall, only TLMs and not their organic analogues were able to initiate cell apoptosis via a mitochondria-mediated pathway. 
Experimental

Enzymatic oxidation of the compounds by the HRP/H 2 O 2 mixture
Enzymatic oxidation of the compounds (25- 
Enzymatic activity estimation of isolated TrxR1 and TrxR2
Highly purified cytosolic (TrxR1) and mitochondrial (TrxR2) thioredoxin reductases were prepared from rat liver according to Luthman and Holmgren 17 and Rigobello and Bindoli, 18 respectively. The protein content of the purified enzyme preparations was measured according to Lowry et al. 19 Thioredoxin reductase activity was determined by estimating the DTNB-reducing properties of the enzymes in the presence of NADPH. Aliquots of highly purified TrxR1 or TrxR2 in 0.2 M Tris-HCl buffer (pH 8.1), 1 mM EDTA and 0.25 mM NADPH were pre-incubated for 5 min with various compounds. Afterwards, the reaction was initiated with 1 mM DTNB and monitored spectrophotometrically at 412 nm for about 10 min. For the formation of oxidized metallocifen derivatives, freshly prepared compounds at increasing concentrations were incubated for 15 min in 0.2 M Tris-HCl buffer (pH 8.1) containing 1 mM EDTA, 0.1 mM H 2 O 2 and 22 nM HRP. Then, TrxR aliquots and 0.25 mM NADPH were added and incubated for 5 min. Finally, the reaction was initiated with 1 mM DTNB and monitored spectrophotometrically at 412 nm for about 10 min.
BIAM assay
First, TLMs and organic tamoxifen were treated with the mixture of 22 nM HRP/0.1 mM 
Determination of total thioredoxin reductase activity in Jurkat cell lysates
The human leukemic lymphoblastoid Jurkat cells were cultured in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% FBS and 1% penicillin/streptomycin (Invitrogen) at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 . Cells (2 x 10 6 ) were incubated with 15 µM compounds for 18 h, then harvested and washed with PBS. Each sample was lysed with a modified RIPA buffer: 150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.5% DOC, 1 mM NaF and an antiprotease cocktail 
Preparation of cytosol and mitochondria enriched fractions and evaluation of thioredoxin reductase activity
To obtain cytosolic and mitochondrial fractions, Jurkat cells (3 x 10 7 ) were grown in 75 cm 2 flasks and then treated with various compounds (30 µM) for 18 h. After incubation, the cells were processed to obtain mitochondria and cytosol enriched fractions essentially following the protocol of Clayton and Shadel. 22 Briefly, the cells were collected, washed with PBS and subjected to hypo-osmotic treatment with 2 mL of 10 mM NaCl, 1.5 mM MgCl 2 and 10 mM Tris-HCl (pH 7.5) for 5 min and gently homogenized using a Dounce tissue grinder. After this treatment, 1.4 mL of 525 mM mannitol, 175 mM sucrose, 12.5 mM Tris-HCl (pH 7.5) and 2.5 mM EDTA (pH 7.5) were rapidly added. Then, the homogenate was diluted to a final volume of 5 mL with 210 mM mannitol, 70 mM sucrose, 5 mM Tris-HCl (pH 7.5) buffer, and 1 mM EDTA (pH 7.5) and subjected to differential centrifugation. The first step was carried out at 1300g for 5 min at 4 °C to discard nuclei and non-disrupted cells. The mitochondrial fraction was pulled down from the supernatant at 15 800g for 15 min at 4 °C and washed twice. The crude soluble supernatant obtained from the mitochondrial isolation step was further centrifuged at 105 000g for 15 min to obtain the cytosolic fraction. Afterwards, mitochondrial samples were lysed using a modified RIPA buffer, as reported in the previous paragraph, and subjected to protein determination with the Lowry assay. 19 In addition, the presence of cytochrome oxidase as a mitochondrial marker was assessed by Western blot analysis using an anti-cytochrome c oxidase subunit 4 monoclonal antibody 1D6. Both cytosolic and mitochondrial fractions (50 µg of proteins) were then tested for thioredoxin reductase activity in a buffer containing 0.2 M NaKPi, 5 mM EDTA (pH 7.4) and 20 mM DTNB. After 2 min, 0.25 mM NADPH was added and the reaction was followed at 412 nm at 25 °C using a Lambda 2 spectrophotometer (PerkinElmer, Waltham, MA, USA).
Redox Western blot analysis of Trx2
The redox state of Trx was detected using a modified Western blot analysis. 23 Incubation was carried out at 37 °C for 20 min. Then, the cell lysates were spun down and precipitated by ice-cold acetone-1 M HCl (98 : 2). The pellets were washed twice with ice-cold acetone-1 M HCl-H 2 O (98 : 2 : 10), re-suspended in 60 µL of urea lysis buffer including 3.5 mM DTT, and incubated for 30 min at 37 °C to reduce the disulfide bonds. Afterwards, 3 µL of 600 mM IAM (final concentration 30 mM) were added to the samples, followed by incubation for 30 min at 37 °C. The protein concentration was determined using the Lowry assay. 19 The proteins were separated by urea-PAGE (7% acrylamide/bis(acrylamide) in 7 M urea) and blotted on a nitrocellulose membrane using a Trans-Blot® Turbot™ System (Bio-Rad Laboratories, Hercules, CA, USA). The membranes were probed with the primary antibody for Trx2 (H75).
Flow cytometric analysis of the mitochondrial membrane potential and superoxide production in Jurkat cells
The drug-influenced cell mitochondrial membrane potential was analyzed by flow cytometry with the fluorescent probe tetramethyl rhodamine methyl ester (TMRM). Jurkat cells (2 x 10 6 ) were treated for 18 h with the compounds (15 µM) and then harvested and resuspended in PBS/10 mM glucose/25 nM TMRM (final concentration) for 15 min at 37 °C in the dark. Induced changes of the membrane potential were estimated with a FACSCanto™ II flow cytometer (Becton-Dickinson, CA, USA) using an argon laser at 585 nm. Cells cultured and treated under the same conditions described above were also probed for mitochondrial superoxide production utilizing the fluorescent probe MitoSOX™ Red.
After treatment with the complexes, Jurkat cells (5 x 10 5 ) were incubated with 1 µM MitoSOX™ in PBS/10 mM glucose for 25 min in the dark, then diluted (1 : 4) and analyzed on a FACSCanto™ using an argon laser at 585 nm.
Determination of short-term cellular ROS production in Jurkat cells
Jurkat cells (4 x 10 5 per well) were seeded in a 96 well plate in PBS/10 mM glucose and then incubated for 1 h with 15 µM dihydrorhodamine 123 (DHR) at 37 °C, 5% CO 2 .
Afterwards, the medium was removed and to each well 100 µM PBS/10 mM glucose supplemented with 10 µM TLMs or organic tamoxifen derivatives was added. Finally, ROS production was estimated by monitoring the fluorescence increase of the probe (Ex = 500 nm, Em = 536 nm), using a Tecan Infinite® M200 PRO plate reader. 
Estimation of cytochrome c release and caspase-3 activation
Results
Synthesis
The TLMs of the group-8 metals Fc-OH-Tam, Rc-OH-Tam and Oc-OH-Tam (Chart 1) used in this study were prepared by following the previously reported protocols and are stable for months in the solid state. 3, 15, 25 The TLMs were obtained as a mixture of Z and E stereomers. We previously found that these stereomers rapidly isomerize in protic medium.
Thus, the experiments reported herein were performed with mixtures of (Z + E) isomers of the 3 complexes. The biochemical behaviour of the TLMs was systematically compared to that of 3 analogous organic tamoxifens, namely Tam, its active metabolite OH-Tam [2] , and OH-Tam [3] , the organic analogue including the same dimethylamino-terminated side chain as in the three TLMs, which was prepared according to the literature. 26
Identification of the products of enzymatic oxidation by the HRP/H 2 O 2 mixture
Enzymatic oxidation of the TLMs and their organic counterparts by the HRP/H 2 O 2 mixture was monitored by UV-visible spectrometry. For Fc-OH-Tam, the progressive appearance of an intense band at 402 nm was observed, which was readily assigned to quinone methide by comparison with the authentic product obtained by chemical oxidation with Ag 2 O ( Fig.   S1 -A, ESI †). 7, 27 This conversion corresponds to a 2-electron, 2-proton abstraction pathway.
The same behaviour was found for Rc-OH-Tam for which a band at 418 nm was observed upon oxidation with HRP/H 2 O 2 (Fig. S1-B did not afford quinone methide, which is characterized by an intense band at around 400 nm. 28 Previous literature data demonstrate that HRP oxidation of OH-Tam[2] rather affords unstable radical species that tend to polymerize. 29 We previously found that enzymatic oxidation of Oc-OH-Tam did not afford quinone methide as did chemical oxidation with Ag 2 O but rather led to a quinone methide carbocation characterized by a band at 331 nm resulting from a two-electron, 1-proton abstraction pathway. 16 This unusual behaviour was assumed to originate from the high stability of carbenium ions derived from osmocene derivatives. 30, 31 Table 1 summarizes the oxidation pathway of the compounds under study and the rate constants of oxidation upon treatment with HRP/H 2 O 2 . As it appears, oxidation of all the compounds proceeded swiftly, with a slightly faster rate observed for ferrocifen than for ruthenocifen and osmocifen. 
In vitro inhibition studies on TrxR1 and TrxR2
The possible inhibitory activity of the three TLMs and the three organic analogues was first investigated on TrxR1 and TrxR2 purified from the rat liver. Experimentally, mixtures of pre-reduced TrxR1 or TrxR2 and various concentrations of each compound were incubated for 5 min before their enzymatic activity was measured. 
Metallocifen interaction with the selenocysteine residue of TrxR
The C-terminal redox active site of TrxR is formed by a Cys-Sec motif (Sec = selenocysteine), which is the target of many electrophiles that inhibit TrxR by alkylation of Cys and/or Sec residues. 32 Mixtures of TrxR1 and oxidized TLMs or organic tamoxifens were allowed to react with BIAM at pH 6 or 8.5 to alkylate the remaining selenolate and/or thiolate groups and the samples were subjected to the Western blot analysis (Fig. 1 ). Very weak bands were observed for TrxR1 samples exposed to the oxidized TLMs and then to BIAM at pH 6 while the organic analogues had no effect.
As a consequence, the three oxidized TLMs equally interacted with Sec by probable alkylation of the highly nucleophilic selenolate group. When alkylation by BIAM was carried out at pH 8.5, the TrxR1 sample exposed to Oc-OH-Tam gave a band weaker than the control, indicating that only oxidized Oc-OH-Tam was able to simultaneously alkylate the thiol groups. In addition, the HRP/H 2 O 2 mixture alone had no effect on the ability of BIAM to alkylate TrxR1 (cnt, lane b and b').
Activities of cytosolic and mitochondrial thioredoxin reductases in Jurkat cells
Jurkat cells (2 x 10 6 ) were incubated with each compound (15 µM) for 18 h. Then, the activity of total TrxR was determined in cell lysates (Fig. S2, ESI †) . A large decrease of the total TrxR activity (60 to 95% inhibition) was observed in cells treated with the three TLMs while Tam and OH-Tam[2] induced a slight increase of activity and OH-Tam[3] had no effect. Additional experiments with Fc-OH-Tam showed that the activity of total TrxR was time-dependent as a slight increase was observed after 3 h followed by progressive and slow inhibition in the next 15 h (Fig. S3, ESI †) . After optimization of the ratio between compounds (30 µM) and cell number (3 x 10 7 ), the activity of TrxR1 and TrxR2 was measured separately in the cytosolic and mitochondrial fractions of Jurkat cells (Fig. 2) . High inhibition of TrxR2 was found for cells exposed to Fc-OH-Tam and Rc-OH-Tam (72% and 79.4% inhibition, respectively), while Oc-OH-Tam was less effective (44% inhibition).
However, organic tamoxifens were significantly less potent (up to 27% inhibition). In contrast, the effect of the three TLMs on TrxR1 was less pronounced (25-36% inhibition) and not much different from that of the organic compounds (12-21% inhibition). 
Mitochondrial thioredoxin (Trx2) redox state in Jurkat cells
As all three TLMs and not the organic analogues induced strong inhibition of TrxR2 in Jurkat cells, the redox state of Trx2 in cells exposed to each compound at 15 µM for 18 h was evaluated by the protein electrophoretic mobility shift assay with iodoacetamide/iodoacetic acid (IAM/IAA) as follows. 33 Lysates of cells incubated with each compound were first treated with IAM to titrate free SH groups, then, after reaction with DTT to reduce disulphide bonds, IAA was added in order to derivatize the SH groups arising from previously oxidized cysteines. The samples were submitted to urea-PAGE under non-reducing conditions and the 3 states of Trx2 (fully oxidized, partially oxidized and fully reduced) were detected by Western blot analysis (Fig. 3) .
Cells incubated with the 3 TLMs showed the accumulation of the fully oxidized form of Trx2, especially those exposed to Fc-OH-Tam (90%) and to a lesser extent 
ROS production and evaluation of the mitochondrial membrane potential (MMP) in Jurkat cells
Short-term (0-30 min) mitochondrial ROS production in Jurkat cells was first measured using the DHR dye, after cell incubation with 10 µM of the TLMs or organic tamoxifens.
We found that the TLMs, but not the organic compounds, increased the basal ROS production during this period (Fig. S4, ESI †) . The long-term mitochondrial superoxide level was then evaluated in Jurkat cells incubated with 15 µM TLMs or organic tamoxifens after 18 h, by flow cytometry analysis using MitoSOX™ Red as a fluorescent probe ( Fig.   4 
left). A very high percentage of cells (72%) incubated with Fc-OH-Tam emitted high
MitoSOX™ fluorescence. This percentage was lower for cells incubated with Rc-OH-Tam
and Oc-OH-Tam (around 40%) while the percentage of cells emitting high MitoSOX™ fluorescence was insignificant for those incubated with the organic tamoxifens (6-8%). The mitochondrial membrane potential (MMP) was evaluated on the same pool of cells by flow cytometry using the fluorescent dye TMRM (Fig. 4 right) . The population of cells with a low MMP was close to 100% for cells incubated with the three TLMs for 18 h while the three organic tamoxifens affected the MMP to a much lower extent (up to 37.5% for OH-Tam [3] ). Interestingly, the rate of depolarization of the mitochondrial membrane was fast for Fc-OH-Tam since the percentage of cells displaying a low MMP was already equal to 42% after 3 h (Fig. S5, ESI †) . 
Activation of the apoptotic pathway
The release of cytochrome c and the state of caspase 3 were examined in Jurkat cells exposed to the three TLMs or the organic tamoxifens for 18 h (Fig. 5 ).
The results clearly show that after incubation with the three TLMs, cytochrome c was released from the mitochondria to the cytosol, whereas it was still located in the mitochondria for the cells treated with organic tamoxifens. Moreover, pro-caspase 3 was only detected in the cells exposed to organic tamoxifens and not in the cells exposed to TLMs. Thus, only TLMs and not organic tamoxifens were able to trigger cell apoptosis by the mitochondria-mediated pathway. 
Intracellular distribution of metals in Jurkat cells
As we found that metallocifens induced mitochondrial impairment we undertook, by ICP-OES, quantification of iron, ruthenium and osmium in the mitochondria and cytosol of cells exposed to Fc-OH-Tam, Rc-OH-Tam and Oc-OH-Tam (Table 3 and Fig. S6, ESI †) . As iron is a metal present in cells, its quantification was also performed in untreated cells. The amounts of iron, osmium and ruthenium in the cytosol and in the mitochondria were in the same order of magnitude, indicating that the three TLMs were all able to accumulate in cells, with a high concentration in the mitochondria. The amount of iron in the cytosol and mitochondria of cells incubated with 30 µM Fc-OH-Tam was significantly higher than the level of iron in the control cells, indicating that it mostly originated from Fc-OH-Tam and not from the endogenous iron pool.
The subcellular distribution of the metals gave an almost exclusive localization in the nuclear crude fractions (45-54%) and mitochondria (37-50%), and only a marginal localization in the cytosol (5-9%) ( Table 4 ). Lipophilic cations are well known to preferentially localize in mitochondria. 34, 35 At physiological pH, the dimethylamino group of TLMs is protonated, thus they can be considered as lipophilic cations. Consequently, they are expected to target mitochondria. Such behaviour is also encountered for other lipophilic metal-based drug candidates of gold(I), 36 osmium(II), 37 and rhenium(I). 38 
Discussion
In vitro inhibition of TrxR by TLMs occurred after their enzymatic oxidation by the HRP/H 2 O 2 mixture, and the products of oxidation were in general more active on the cytosolic isoform (IC 50 in the 0.06-1.2 µM range) than on the mitochondrial form (IC 50 in the 3.9-10.9 µM range, Table 1 ). In contrast, oxidized organic tamoxifen derivatives were These differences may be accountable to the much lower redox potential of ferrocene derivatives (+0.4 V for Fc, 7 versus +0.8 V for Rc, 44 and +0.6 V for Oc, 15 in their analogous metallociphenols). Indeed, according to Kovacic, only the metallocenes with a redox potential between +0.4 and -0.44 V display anticancer activity since this range of potential is favorable for in vivo electron transfer and redox cycling. 45 In our series, only
Fc-OH-Tam fulfils this requirement.
Conclusion
We showed that TLMs became strong inhibitors of both isoforms of TrxR after their 
